Abstract: The invention concerns in one embodiment a method for treating glaucoma or elevated IOP in a patient comprising administering to the patient an effective amount of a composition comprising an agent that inhibits PAI-1 expression or PAI-1 activity. Another embodiment of the present invention is a method of treating a PAI-1-associated ocular disorder in a subject in need, comprising administering to the patient an effective amount of a composition comprising an agent that inhibits PAI-1 activity or expression.
Type:
Application
Filed:
April 9, 2009
Publication date:
August 13, 2009
Applicant:
ALCON RESEARCH, LTD.
Inventors:
Debra L. Fleenor, Allan R. Shepard, Iok-Hou Pang, Mark R. Hellberg, Abbot F. Cark
Abstract: In one aspect, the present invention provides a diffractive ophthalmic lens (e.g., a diffractive IOL) that includes an optic having an anterior surface and a posterior surface, where the optic provides a far focus. A frustrated diffractive structure comprising a plurality of diffractive zones is disposed on at least one of those surfaces so as to provide a near focus. Each zone is separated from an adjacent zone by a zone boundary that imparts an optical delay to the incident light. Further, at least two consecutive zone boundaries are configured such that a difference between their associated phase delays for at least one wavelength of the incident light is greater than about ΒΌ wavelength so as to direct a portion of the incident light to a location between the near and far foci.
Abstract: A method of operating an ultrasonic handpiece by pulsing the power supplied to the handpiece and varying the amplitude of the power during the power pulse.
Abstract: The present invention relates to a formulation comprising a N-halogenated amino acid and a phase transfer agent. The present invention also describes a method for disinfecting and/or cleaning a contact lens comprising contacting a contact lens with a formulation comprising a N-halogenated amino acid salt for a time sufficient to disinfect and/or clean the lens.
Type:
Application
Filed:
April 30, 2008
Publication date:
August 6, 2009
Applicant:
ALCON RESEARCH, LTD.
Inventors:
L. Wayne Schneider, Wesley Wehsin Han, Masood A. Chowhan, David W. Stroman, W. Dennis Dean, Michael S. Gaines
Abstract: System and method for identifying a component, such as an optical probe or pneumatic scissors, of an ophthalmic surgical device. A component of a surgical device includes an identifier, such as a RFID tag. Data from the RFID tag is transmitted to a RFID reader in the device. A controller determines whether the component corresponding to the received data is operable with the surgical device based on criteria, such as whether the received data is an authorized code that matches data stored in memory or whether the received data solves or satisfies an algorithm. The authorized codes are selected from a larger set of available codes. The controller enables or disables the operation of the device with the component based on whether the criteria is satisfied, the number of uses of the component, an amount of time that has passed since the component has been used, or a geographic location.
Type:
Grant
Filed:
December 15, 2004
Date of Patent:
August 4, 2009
Assignee:
Alcon, Inc.
Inventors:
Kirk W. Todd, Johan G. Ekvall, Frederick M. Reed, T. Scott Rowe, Christopher Horvath
Abstract: A medical equipment tray system includes a two piece platform, a foldable liner which fits over the two piece platform and a handpiece cradle which may be elevated with respect to the two piece platform.
Abstract: A laser probe includes an emitting optical fiber, optics, and two or more receiving optical fibers. The emitting optical fiber emits a beam of laser light. The optics diffract the beam of light emitted by the emitting optical fiber. The receiving optical fibers each receive a beam of light diffracted by the optics.
Abstract: The present invention provides compositions and methods for treating otic disorders. More specifically, the present invention describes the use of agents that down-regulate expression of Tanis and/or p21Waf1/Cip1/Sd1 genes to treat such disorders of the ear.
Abstract: Disclosed are methods of treating allergic conjunctivitis and non-infectious rhinitis in a subject that involve topically administering to the subject a composition comprising olopatadine and cilomilast.
Type:
Application
Filed:
March 18, 2009
Publication date:
July 16, 2009
Applicant:
Alcon Research, Ltd.
Inventors:
John M. Yanni, Daniel A. Gamache, Steven T. Miller, Clay Beauregard
Abstract: A microsurgical system capable of priming its aspiration circuit using a pressurized gas source, a pressurized infusion fluid source, an aspiration chamber fluidly coupled to the pressurized gas source and the pressurized infusion fluid source, and a computer.
Type:
Grant
Filed:
October 16, 2006
Date of Patent:
July 14, 2009
Assignee:
Alcon, Inc.
Inventors:
David M. Domash, Mark A. Hopkins, John C. Huculak, Nader Nazarifar
Abstract: A caster attachment system includes an upper section and a lower section. The upper section mounts to a piece of equipment. The lower section provides a post for the mounting of a caster. A shaped key on the lower section fits within a receiver socket on the upper portion. The upper section and the lower section are held together by a threadable connection.
Abstract: An RFID ring illumination system includes an illumination ring and a printed circuit board. The illumination ring has a light refracting layer integral with the front of a surgical machine. The printed circuit board is located behind and close to the front of the surgical machine. The printed circuit board has an RFID reader antenna and a light source mounted on it. The light emitted by the light source travels through the illumination ring and is visible from the front of the surgical machine.
Abstract: Topical ophthalmic compositions that form a gel or partial gel upon application to the eye are described. The compositions are particularly useful as artificial tears and ocular lubricants, but may also be utilized for the topical delivery of pharmaceutically active compounds to the eye. The compositions contain a polysaccharide/borate gelling system. The polysaccharides that may be utilized contain cis-diol groups and have a structure that is predominately linear, with a slight degree of branching.
Abstract: Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.
Abstract: The use of 5,6,7-trihydroxyheptanoic acid and analogs is disclosed for the treatment of asthma, allergic rhinitis, and skin disorders such as allergic dermatitis, contact hypersensitivity, urticaria (hives), rosacea, or psoriasis.
Type:
Application
Filed:
February 19, 2009
Publication date:
June 18, 2009
Applicant:
Alcon Research, Ltd.
Inventors:
Peter G. Klimko, Clay Beauregard, Bryon S. Severns
Abstract: Methods of making 1-alkylindazoles are described. The methods involve reacting a 2-alkylaminobenzonitrile with a nitrosating agent followed by reduction-cyclization of the resulting nitrosamine to form a 1-alkyl-3-aminoindazole. The 1-alkyl-3-aminoindazole can be deaminated to form a 1-alkylindazole which ultimately can be used to form desired indazoles which are preferably pharmaceutically active products. The process of the present invention further permits the formation of enantiomerically enriched or pure indazoles such as aminoalkyl indazoles.
Type:
Application
Filed:
February 10, 2009
Publication date:
June 11, 2009
Applicant:
Alcon, Inc.
Inventors:
Pete Delgado, Raymond E. Conrow, W. Dennis Dean
Abstract: Disclosed are soft, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers and a tack-reducing macromer additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other ophthalmic or otorhinolaryngological devices, such as contact lenses, keratoprostheses, corneal inlays or rings; otological ventilation tubes and nasal implants.
Type:
Application
Filed:
January 23, 2009
Publication date:
May 28, 2009
Applicant:
Alcon,Inc.
Inventors:
Diana M. Cordova, Mutlu Karakelle, Chance Lehman, Douglas C. Schlueter, Joseph I. Weinschenk, III
Abstract: Disclosed are soft, high refractive index, acrylic materials. These materials, especially useful as intraocular lens materials, contain one or more aryl acrylic hydrophobic monomers as principal device-forming monomers and a tack-reducing macromer additive. In addition to their use as intraocular lens materials, the present materials are also suitable for use in other ophthalmic or otorhinolaryngological devices, such as contact lenses, keratoprostheses, corneal inlays or rings; otological ventilation tubes and nasal implants.
Type:
Application
Filed:
January 23, 2009
Publication date:
May 21, 2009
Applicant:
Alcon, Inc.
Inventors:
Diana M. Cordova, Mutlu Karakelle, Chance Lehman, Douglas C. Schlueter, Joseph I. Weinschenk, III